charlotte.duncan

Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer

Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg 150 150 Lysogene Lysogene https://lysogene.com/wp-content/themes/crocal/images/empty/thumbnail.jpg February 3, 2023 February 2, 2023

Paris, France — 03 February 2023 at 6:00 pm CET — Lysogene (FR0013233475 – LYS), a…

Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer

Lysogene COVID-19 update

Lysogene is developing therapies for children with CNS diseases.

Delivering Gene Therapy’s Promise

©2022 Lysogene. All rights reserved.

Get In Touch